| |||||||||

Revenue by Geography (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Revenue - International | 8.77B | 8.75B | 8.19B | 8.54B | 8.55B | |||
| Revenue - US | 10.6B | 10.5B | 9.73B | 10.8B | 12.0B | |||
| Total Revenue | 19.4B | 19.2B | 17.9B | 19.3B | 20.6B | |||
Revenue by Segment (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Revenue - Nutritionals | 0 | 0 | 0 | 2.52B | 2.88B | |||
| Revenue - Other Health Care | 0 | 0 | 0 | 1.16B | 0 | |||
| Revenue - Plavix | 0 | 0 | 0 | 4.75B | 5.60B | |||
| Revenue - Avapro/Avalide | 0 | 0 | 0 | 1.20B | 1.29B | |||
| Revenue - Pravachol | 0 | 0 | 0 | 443M | 203M | |||
| Revenue - Reyataz | 0 | 0 | 0 | 1.12B | 1.29B | |||
| Revenue - Sustiva | 0 | 0 | 0 | 956M | 1.15B | |||
| Revenue - Baraclude | 0 | 0 | 0 | 275M | 541M | |||
| Revenue - Erbitux | 0 | 0 | 0 | 692M | 749M | |||
| Revenue - Taxol | 0 | 0 | 0 | 422M | 385M | |||
| Revenue - Sprycel | 0 | 0 | 0 | 158M | 310M | |||
| Revenue - Ixempra | 0 | 0 | 0 | 15.0M | 101M | |||
| Revenue - Abilify | 0 | 0 | 0 | 1.66B | 2.15B | |||
| Revenue - Orencia | 0 | 0 | 0 | 231M | 441M | |||
| Total Revenue | 19.4B | 19.2B | 17.9B | 19.3B | 20.6B | |||
| ||||||